These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32238335)

  • 1. Effectiveness of One-Way Text Messaging on Attendance to Follow-Up Cervical Cancer Screening Among Human Papillomavirus-Positive Tanzanian Women (Connected2Care): Parallel-Group Randomized Controlled Trial.
    Linde DS; Andersen MS; Mwaiselage J; Manongi R; Kjaer SK; Rasch V
    J Med Internet Res; 2020 Apr; 22(4):e15863. PubMed ID: 32238335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Text messages to increase attendance to follow-up cervical cancer screening appointments among HPV-positive Tanzanian women (Connected2Care): study protocol for a randomised controlled trial.
    Linde DS; Andersen MS; Mwaiselage JD; Manongi R; Kjaer SK; Rasch V
    Trials; 2017 Nov; 18(1):555. PubMed ID: 29162148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability and feasibility of self-sampling and follow-up attendance after text message delivery of human papillomavirus results: A cross-sectional study nested in a cohort in rural Tanzania.
    Mremi A; Linde DS; Mchome B; Mlay J; Schledermann D; Blaakaer J; Rasch V
    Acta Obstet Gynecol Scand; 2021 Apr; 100(4):802-810. PubMed ID: 33555038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability of text messages and knowledge change for cervical cancer screening: a Tanzanian mixed methods study.
    Løkke KF; Rasch V; Mwaiselage J; Gammeltoft T; Linde DS
    BMJ Open; 2022 Sep; 12(9):e058450. PubMed ID: 36123109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competing needs: a qualitative study of cervical cancer screening attendance among HPV-positive women in Tanzania.
    Linde DS; Rasch V; Mwaiselage JD; Gammeltoft TM
    BMJ Open; 2019 Feb; 9(2):e024011. PubMed ID: 30819704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
    Lilliecreutz C; Karlsson H; Spetz Holm AC
    PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol.
    Nakisige C; Trawin J; Mitchell-Foster S; Payne BA; Rawat A; Mithani N; Amuge C; Pedersen H; Orem J; Smith L; Ogilvie G
    BMC Public Health; 2020 Jan; 20(1):142. PubMed ID: 32005202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial.
    Winer RL; Lin J; Tiro JA; Miglioretti DL; Beatty T; Gao H; Kimbel K; Thayer C; Buist DSM
    JAMA Netw Open; 2019 Nov; 2(11):e1914729. PubMed ID: 31693128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stepwise strategy to improve cervical cancer screening adherence (SCAN-Cervical Cancer) - Automated text messages, phone calls and reminders: Population based randomized controlled trial.
    Firmino-Machado J; Varela S; Mendes R; Moreira A; Lunet N;
    Prev Med; 2018 Sep; 114():123-133. PubMed ID: 29894717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics.
    Di Salvo I; Mnzava D; Nicoletti GJ; Senkoro E; Ndege RC; Huang DJ; Makunja NT; Kassiga GI; Kaufmann AM; Weisser M; Kind AB
    BMC Health Serv Res; 2023 Mar; 23(1):234. PubMed ID: 36894985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
    Swanson M; Ibrahim S; Blat C; Oketch S; Olwanda E; Maloba M; Huchko MJ
    BMC Womens Health; 2018 Jul; 18(1):116. PubMed ID: 29970063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Providing Cervical Cancer Screening Results via Cell Phone Affects Patient Follow-Up Rates in Western Kenya.
    Huchko MJ; Saduma I; Blat C; Oketch S; Bukusi EA
    J Glob Oncol; 2019 Jun; 5():1-8. PubMed ID: 31246553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of text message reminders on cryotherapy uptake among women testing positive for HPV in western Kenya: a prospective cohort study.
    Choi Y; Ibrahim S; Park LP; Bukusi EA; Huchko MJ
    BMC Womens Health; 2024 Jan; 24(1):32. PubMed ID: 38218782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of HPV self-collection kits on cervical cancer screening uptake among under-screened women from low-income US backgrounds (MBMT-3): a phase 3, open-label, randomised controlled trial.
    Pretsch PK; Spees LP; Brewer NT; Hudgens MG; Sanusi B; Rohner E; Miller E; Jackson SL; Barclay L; Carter A; Wheeler SB; Smith JS
    Lancet Public Health; 2023 Jun; 8(6):e411-e421. PubMed ID: 37182529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of a culturally tailored text messaging program for promoting cervical cancer screening in accra, Ghana: a quasi-experimental trial.
    Addo-Lartey AA; Bonful HA; Sefenu RS; Abagre TA; Asamoah A; Bandoh DA; Awua AK; Adu-Aryee NA; Dedey F; Adanu RMK; Okuyemi KS
    BMC Womens Health; 2024 Jan; 24(1):22. PubMed ID: 38172883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
    Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
    Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mobile Phone Ownership and Use Among Women Screening for Cervical Cancer in a Community-Based Setting in Western Kenya: Observational Study.
    Stocks J; Ibrahim S; Park L; Huchko M
    JMIR Public Health Surveill; 2022 Jun; 8(6):e28885. PubMed ID: 35671089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trial.
    Montealegre JR; Anderson ML; Hilsenbeck SG; Chiao EY; Cantor SB; Parker SL; Daheri M; Bulsara S; Escobar B; Deshmukh AA; Jibaja-Weiss ML; Zare M; Scheurer ME
    Trials; 2020 Oct; 21(1):872. PubMed ID: 33087164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of mobile technologies for the prevention of cervical cancer in Santiago, Chile study protocol: a randomized controlled trial.
    Momany MC; Martinez-Gutierrez J; Soto M; Capurro D; Ciampi F; Thompson B; Puschel K
    BMC Cancer; 2017 Dec; 17(1):847. PubMed ID: 29237420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and Acceptability of Targeted Text Message Reminders in Colorectal Cancer Screening: Randomized Controlled Trial (M-TICS Study).
    Vives N; Travier N; Farre A; Binefa G; Vidal C; Pérez Lacasta MJ; Ibáñez-Sanz G; Niño de Guzmán EP; Panera JA; Garcia M;
    JMIR Public Health Surveill; 2024 Jul; 10():e57959. PubMed ID: 39083331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.